Contineum Therapeutics, Inc. (CTNM)
8.28
-0.07
(-0.84%)
USD |
NASDAQ |
Oct 22, 09:49
Contineum Therapeutics Price : 8.28 for Oct. 22, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | 8.49 | 8.79 | 8.15 | 8.35 | 1.117M |
| Oct 20, 2026 | 7.38 | 8.70 | 7.145 | 8.46 | 2.201M |
| Oct 19, 2026 | 7.01 | 7.45 | 6.725 | 7.44 | 1.796M |
| Oct 16, 2026 | 7.87 | 7.87 | 6.95 | 7.08 | 1.108M |
| Oct 15, 2026 | 8.25 | 8.56 | 7.72 | 7.90 | 1.021M |
| Oct 14, 2026 | 8.21 | 8.796 | 7.96 | 8.14 | 1.015M |
| Oct 13, 2026 | 8.56 | 8.94 | 8.095 | 8.42 | 2.649M |
| Oct 12, 2026 | 9.90 | 11.54 | 8.425 | 8.565 | 8.468M |
| Oct 09, 2026 | 13.17 | 13.86 | 12.94 | 13.38 | 885591.0 |
| Oct 08, 2026 | 12.55 | 13.29 | 12.39 | 13.18 | 1.178M |
| Oct 07, 2026 | 12.42 | 13.01 | 12.31 | 12.73 | 707729.0 |
| Oct 06, 2026 | 12.88 | 12.88 | 12.17 | 12.65 | 761922.0 |
| Oct 05, 2026 | 13.14 | 13.30 | 12.41 | 12.72 | 508398.0 |
| Oct 02, 2026 | 13.15 | 13.24 | 12.58 | 13.12 | 794261.0 |
| Oct 01, 2026 | 13.30 | 13.50 | 12.62 | 12.99 | 773993.0 |
| Sep 30, 2026 | 11.59 | 13.54 | 11.59 | 13.42 | 1.598M |
| Sep 29, 2026 | 12.83 | 13.08 | 10.84 | 11.50 | 856267.0 |
| Sep 28, 2026 | 12.38 | 13.36 | 11.95 | 12.73 | 534128.0 |
| Sep 25, 2026 | 12.57 | 12.88 | 12.10 | 12.56 | 404930.0 |
| Sep 24, 2026 | 12.49 | 12.74 | 11.40 | 12.49 | 632162.0 |
| Sep 23, 2026 | 13.33 | 13.33 | 12.44 | 12.51 | 550258.0 |
| Sep 22, 2026 | 13.74 | 14.00 | 13.19 | 13.40 | 770298.0 |
| Sep 21, 2026 | 13.69 | 13.89 | 13.44 | 13.55 | 638481.0 |
| Sep 18, 2026 | 13.23 | 13.89 | 13.14 | 13.53 | 2.139M |
| Sep 17, 2026 | 14.07 | 14.40 | 12.86 | 13.21 | 580102.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.96 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Arvinas, Inc. | 7.60 |
| Fulcrum Therapeutics, Inc. | 3.71 |
| Definium Therapeutics, Inc. | 35.93 |
Price Related Metrics
| Price to Book Value | 1.300 |
| Earnings Yield | -20.99% |
| Market Cap | 311.44M |